Epidemiological Transition and the Crisis of the Treatment Model: The Need for a Shift Toward Preventive and Integrative Healthcare

1. Introduction

At present, the modern healthcare system is facing a deep systemic crisis affecting its fundamental principles and sustainability. Despite significant technological progress and advances in precision medicine, artificial intelligence, and gene therapy, the overall health status of the global population is deteriorating. The central contradiction lies in the fact that increased healthcare funding and improved diagnostics are not accompanied by a substantial reduction in the prevalence of chronic non-communicable diseases such as cardiovascular diseases, diabetes, cancer, and chronic respiratory conditions. [1]

This crisis is structurally determined and rooted in the historical and systemic characteristics of healthcare development. The modern healthcare system was formed in the first half of the 20th century, when the primary threats to health were infectious diseases and injuries. An approach focused on treating already manifested diseases proved effective against infections and led to a rapid and significant increase in life expectancy. Today, however, the disease structure has changed: instead of acute infections, chronic diseases now predominate, requiring not one-time treatment but long-term management, including modifications in lifestyle, environment, and the social determinants of health for each individual. [1,2]

The gap between the excessive focus on high technologies and the real needs of the population is becoming increasingly evident. Healthcare systems often prioritize expensive treatments at advanced stages of disease while underestimating simple and effective preventive measures. As a result, a model emerges in which financial interests, insurance structures, and pharmaceutical industry profits tend to outweigh the actual improvement of population health. [3]

The central question of this article is as follows: why does the modern healthcare system, despite its immense technological potential, fail to effectively address the burden of non-communicable diseases and global inequality?

This study contributes to the existing literature by integrating epidemiological transition theory with a political economy perspective to explain the persistence of treatment-oriented healthcare systems despite the dominance of non-communicable diseases. It further provides a structured synthesis linking global disease patterns, institutional incentives, and health system outcomes within a single analytical framework.

2. Materials and Methods

This study was conducted as a narrative analytical review aimed at examining the structural mismatch between contemporary disease patterns and the organization of modern healthcare systems. No primary data were collected. The analysis is based on secondary data derived from publicly available sources, primarily the Global Burden of Disease (GBD) study and reports from the World Health Organization (WHO), which provide standardized estimates of mortality, morbidity, and risk factors across populations. These sources were selected due to their methodological rigor, global scope, and relevance to population-level health trends.

Additional evidence was obtained through targeted searches of PubMed, Scopus, and Google Scholar for publications in English from approximately 2000 to 2026, using combinations of terms related to non-communicable diseases, epidemiological transition, health system organization, prevention, and global health inequality. Sources were selected based on relevance to the research question and citation prominence. Priority was given to peer-reviewed publications, including systematic reviews, large observational studies, and high-impact journal articles. Policy reports and institutional publications were also included to capture economic and governance dimensions that are not fully represented in clinical or epidemiological literature.

The study follows a narrative synthesis approach in which findings from non-uniform data sources are examined together rather than quantitatively pooled. This analysis is structured through the combined use of epidemiological transition theory, health systems and economic analysis, and political economy perspectives. These frameworks were used to interpret patterns in disease burden, healthcare financing, and global inequalities, and to identify structural relationships between institutional incentives and health outcomes.

Sources were included if they provided quantitative data on disease burden, examined healthcare system structure or policy, or addressed prevention and integrative approaches within a population health context. Non-analytical opinion pieces and non-indexed sources were excluded unless required for historical or conceptual background.

This methodological approach has inherent limitations. As a narrative review, it does not follow a formal systematic protocol and may therefore be subject to selection bias. The integration of diverse types of evidence introduces interpretive subjectivity, and causal inferences are based on existing literature rather than primary empirical analysis.

3. Results

3.1. Epidemiological Transition and Disease Patterns

The concept of the epidemiological transition, proposed by Abdel Omran, describes the shift in dominant causes of morbidity and mortality as societies develop, moving from infectious diseases and famine toward chronic and lifestyle-related conditions. Most countries are currently in the stage characterized by the predominance of non-communicable diseases, reflecting a structural transformation in population health profiles [4].

Data from the Global Burden of Disease study indicate that non-communicable diseases have become the leading cause of mortality in all regions except those with the lowest Socio-Demographic Index. In 2021, non-communicable diseases accounted for approximately 43.8 million deaths, representing about 64.5% of total global mortality [1].

3.2. Distribution and Trends in Major Non-Communicable Diseases

The distribution of major non-communicable diseases demonstrates a dominant contribution of cardiovascular diseases, followed by neoplasms, chronic respiratory diseases, and diabetes mellitus. In 2021, cardiovascular diseases accounted for 19.4 million deaths (28.6% of total mortality), neoplasms for 9.88 million (14.6%), chronic respiratory diseases for 4.41 million (6.5%), and diabetes mellitus for 1.65 million (2.4%). Together, these four groups accounted for approximately 37.6 million deaths, representing around 55% of total global mortality. Trends indicate a continued increase in overall burden, with cardiovascular diseases showing moderate growth, neoplasms demonstrating a steady increase, chronic respiratory diseases showing regional variability, and diabetes mellitus exhibiting the most rapid growth (AAPC +2.41%) [1].

Diabetes mellitus demonstrates the fastest growth rate in incidence among major non-communicable diseases [1,5].

3.3. Regional Variation and the Double Burden of Disease

The epidemiological transition demonstrates substantial regional heterogeneity. In high-income countries (high SDI), higher incidence rates of non-communicable diseases are observed, including diabetes, which reaches approximately 461 cases per 100,000 population. In contrast, low-income countries continue to experience high mortality from infectious, maternal, and perinatal conditions [1].

Low- and middle-income countries (LMICs) exhibit a concurrent burden of infectious diseases and non-communicable diseases. In these settings, populations are exposed simultaneously to communicable diseases such as tuberculosis, HIV, and malaria, and to increasing prevalence of non-communicable diseases associated with urbanization and lifestyle changes [6,7]. This coexistence of disease categories within the same populations is described as the “double burden of disease” [2].

3.4. Future Projections of Non-Communicable Disease Burden (to 2050)

Projections based on current trends indicate a continued increase in the global burden of non-communicable diseases. By 2050, annual mortality attributable to non-communicable diseases is estimated to reach approximately 75.5 million deaths. Cardiovascular diseases are projected to remain the leading contributor, accounting for up to 86% of total non-communicable disease mortality [1].

In parallel, the global burden of disease measured in disability-adjusted life years (DALYs) is projected to reach approximately 2.44 billion, reflecting a substantial increase in long-term morbidity and functional impairment at the population level [1].

3.5. Structural Inequality in Healthcare Systems

The global healthcare system is characterized by uneven distribution of resources, technologies, and scientific capacity. A significant concentration of medical research and development investment is observed in high-income countries, accounting for more than 90% of global R&D expenditure. This concentration limits participation in research prioritization and innovation among lower-income regions [8,9,10].

Access to medical technologies is further shaped by intellectual property frameworks, including the TRIPS agreement, which enables patent-based pricing structures. These mechanisms are associated with reduced affordability and limited access to essential medicines in lower-income settings. Constraints on the use of compulsory licensing during health crises have also been documented [8,11].

3.6. COVID-19 as an Empirical Case of Global Inequality

Empirical evidence from the COVID-19 pandemic demonstrates substantial disparities in access to medical technologies. In 2021, more than 70% of vaccine doses were allocated to high-income countries, while vaccination coverage in low-income countries remained between 1% and 4% [8,12].

The distribution of vaccines showed a high degree of concentration, with a Gini coefficient of approximately 0.88, indicating significant inequality in access to resources across countries. A large proportion of populations in low-income regions remained without access to vaccination despite its role in reducing mortality.

Public financing contributed substantially to vaccine development, with investments of approximately $14 billion in high-income countries, while access to resulting technologies remained uneven across regions [13].

3.7. Economic Burden and System-Level Inefficiency

Non-communicable diseases are associated with a substantial global economic burden. Projections estimate total global economic losses of approximately $47 trillion by 2030. In the European region, non-communicable diseases account for approximately 1.8 million preventable deaths annually and impose costs of around $514 billion per year [28,30].

Healthcare expenditure patterns indicate a limited allocation of resources to prevention. In OECD countries, spending on preventive measures accounts for less than 0.5% of GDP, while curative care constitutes a substantially larger proportion of total healthcare expenditure [18].

Estimates of return on investment in public health interventions indicate that preventive measures yield high economic returns, with an approximate ratio of 1:14 [31,32].

3.8. Multimorbidity and System Fragmentation

Non-communicable diseases frequently occur in combination rather than isolation. In low- and middle-income countries, there is a growing prevalence of multimorbidity, with individuals simultaneously affected by conditions such as hypertension, diabetes, and chronic respiratory diseases [6,33].

Healthcare systems are organized into specialized domains, including cardiology, endocrinology, and pulmonology, reflecting a fragmented structure of care delivery. This specialization is associated with the management of individual diseases rather than coexisting conditions, contributing to increased medication use and complexity of care [6,21].

Long-term management of chronic conditions results in sustained healthcare utilization and ongoing care requirements at both system and household levels [3,28].

4. Discussion

4.1. Structural Mismatch Between Disease Burden and Healthcare Systems

The findings indicate a fundamental mismatch between the current structure of global disease burden and the organization of modern healthcare systems. While non-communicable diseases have become the dominant drivers of mortality and morbidity, healthcare systems remain primarily oriented toward the treatment of acute and episodic conditions. This structural configuration reflects a model originally designed to address infectious diseases and injuries, where short-term interventions and discrete therapeutic episodes were sufficient. In contrast, chronic diseases require continuous management, long-term behavioral modification, and sustained engagement with social and environmental determinants of health [1,2].

As a result, increasing investments in medical technologies and treatment capacity are not accompanied by proportional improvements in population health outcomes. The system continues to prioritize late-stage intervention rather than early-stage prevention, creating a persistent gap between healthcare delivery and actual health needs [3].

4.2. Economic and Political Drivers of Treatment-Oriented Systems

The persistence of treatment-oriented healthcare systems is closely linked to underlying economic and political incentive structures. Within existing institutional frameworks, treatment provides immediate, measurable, and politically visible outcomes, whereas prevention represents a long-term investment with delayed and less tangible results [18].

Political decision-making cycles further reinforce this orientation. Governments operating within limited electoral timeframes tend to prioritize interventions that yield rapid and demonstrable effects, such as expanding access to specialized care or investing in medical infrastructure. Preventive strategies, including lifestyle interventions and public health programs, often require extended time horizons before measurable outcomes become apparent, reducing their attractiveness within short-term policy agendas [3,19].

Economic incentives also contribute to this imbalance. Chronic diseases generate sustained demand for pharmaceutical products and medical services, creating stable revenue streams within healthcare markets. In contrast, effective prevention reduces long-term consumption of healthcare services and therefore does not align with prevailing economic models centered on volume and utilization [20,21].

4.3. Historical Institutionalization of the Biomedical Model

The dominance of treatment-oriented healthcare systems is historically rooted in the institutionalization of the biomedical model during the early twentieth century. The Flexner Report of 1910 played a central role in standardizing medical education and establishing a scientific, laboratory-based approach as the foundation of clinical practice [14,15].

This transformation resulted in the consolidation of a single dominant paradigm of medicine, accompanied by the closure of institutions associated with alternative medical traditions, including herbal medicine, homeopathy, and naturopathy. The reform significantly reduced the diversity of medical approaches and reinforced a model focused on pathophysiology and intervention [16,17].

At the same time, the role of physicians shifted toward the diagnosis and treatment of established disease, while preventive and public health functions became increasingly separated from clinical practice. This institutional configuration contributed to the prioritization of therapeutic interventions over health maintenance and disease prevention, shaping the trajectory of modern healthcare systems toward an intervention-centered model.

4.4. Technological Orientation and Its Limits

The increasing reliance on technological solutions, including artificial intelligence and digital health tools, reflects a broader shift toward technocratic approaches in healthcare systems. These technologies are frequently presented as comprehensive solutions to complex health challenges; however, their application often redirects attention away from underlying structural determinants of health, such as socioeconomic conditions, environmental exposures, and lifestyle factors [22].

Digital health models are commonly based on the assumption that access to information leads to rational behavioral change. This assumption does not adequately account for real-world constraints, including time limitations, financial pressures, and social environments that restrict individuals’ ability to modify health-related behaviors [23,24,25].

In addition, the deployment of advanced technologies may reinforce existing inequalities. Access to digital tools and the ability to benefit from them are unevenly distributed, with more affluent populations deriving greater advantage, while vulnerable groups experience limited improvements in health outcomes. Algorithmic bias and unequal access to technological infrastructure further contribute to disparities in care and health outcomes [26,27].

4.5. System Consequences: Inefficiency and Inequality

The observed configuration of healthcare systems is associated with increasing economic burden and systemic inefficiency. The prioritization of late-stage treatment over early prevention leads to the allocation of substantial resources toward high-cost interventions, while comparatively low-cost preventive measures remain underfunded. This imbalance reflects a structural misalignment between resource allocation and potential health gains [18,28,31].

The economic implications extend beyond healthcare expenditures to broader societal impacts, including reduced productivity and increased long-term financial strain on social systems. The persistence of these patterns indicates that current healthcare models are not optimized for economic sustainability in the context of chronic disease prevalence [28,29,30].

At the global level, inequality emerges as a structural outcome of the existing system. The COVID-19 pandemic provides a clear example of how technological capacity does not translate into equitable outcomes. Despite rapid development of effective medical interventions, access to these technologies remained uneven across countries, reflecting disparities in economic power, institutional capacity, and control over production and distribution mechanisms [8,11,12,13].

4.6. Multimorbidity and Fragmentation of Care

The increasing prevalence of multimorbidity presents a significant challenge to healthcare systems organized around single-disease frameworks. Patients frequently experience multiple chronic conditions simultaneously, requiring coordinated and continuous management rather than isolated interventions [6,33].

However, healthcare systems remain structured around specialized disciplines, such as cardiology, endocrinology, and pulmonology, each focused on individual disease categories. This fragmentation limits the ability to address complex patient needs and contributes to the accumulation of multiple treatments and medications, increasing the risk of adverse effects and reducing overall quality of care [6,21].

This structural limitation reflects a broader misalignment between system design and the realities of chronic disease, where effective management requires integrated, patient-centered approaches rather than compartmentalized care pathways.

4.7. Preventive and Integrative Paradigm as Systemic Response

The limitations of the current treatment-oriented healthcare model indicate the need for a shift toward a preventive and integrative paradigm. Within this framework, health is conceptualized not as the absence of disease, but as a dynamic equilibrium within a complex adaptive system, requiring consideration of biological, psychological, and environmental dimensions [34].

This approach emphasizes a systemic understanding of disease, in which pathological conditions are interpreted as manifestations of broader imbalances rather than isolated dysfunctions. It incorporates individualized assessment of lifestyle, behavioral patterns, and social determinants of health, aligning with principles of personalized and lifestyle medicine [35,36,37,38].

A central component of this paradigm is the prioritization of prevention. The focus shifts from managing established disease to preventing its onset and progression, particularly at preclinical stages. This orientation is consistent with established frameworks of disease prevention and health promotion and aligns with the principles of Primary Health Care, which emphasize accessibility, community-based interventions, and long-term population health outcomes [39].

4.8. Role of Traditional and Integrative Medicine (WHO Framework)

At the level of global health policy, there is increasing recognition of the role of traditional, complementary, and integrative medicine within healthcare systems. The World Health Organization’s Global Strategy on Traditional Medicine 2025–2034 provides a structured framework for the integration of scientifically validated traditional practices into national health systems [40,41].

The strategy emphasizes several key directions, including the scientific validation of traditional therapies using contemporary biomedical methodologies, the development of regulatory standards to ensure safety and quality, and the incorporation of selected practices into clinical care as complementary approaches. These may include interventions such as yoga, acupuncture, and naturopathy, particularly in the context of chronic disease management, rehabilitation, and reduction of treatment-related side effects.

This integration is supported by the historical orientation of traditional medical systems toward health maintenance and disease prevention. In resource-constrained settings, such approaches may contribute to expanding access to care and supporting progress toward universal health coverage, particularly in low- and middle-income countries [40,41].

4.9. Risks and Constraints of Integrative Approaches

The implementation of integrative healthcare models is associated with several risks and constraints that require critical consideration. One of the primary concerns is the potential erosion of scientific standards through the inclusion of practices lacking sufficient empirical validation. In the absence of rigorous regulatory frameworks, there is a risk that unproven or ineffective interventions may be promoted under the label of “holistic” care [21,42].

Methodological challenges further complicate evaluation, as many traditional and integrative interventions operate through multifactorial mechanisms that are not easily assessed using conventional randomized controlled trial designs. This creates potential for interpretive ambiguity and inconsistent evidence standards [40].

Commercialization represents an additional constraint. The expansion of the wellness and supplement industries has led to the commodification of holistic concepts, often reducing them to marketable products rather than comprehensive lifestyle interventions. This process reproduces elements of the same reductionist logic observed in conventional biomedical systems, while potentially misleading consumers and undermining evidence-based practice [20].

Equity considerations also remain critical. Integrative approaches may disproportionately benefit higher-income populations with access to resources such as high-quality nutrition, structured lifestyle programs, and complementary therapies. Without policy-level integration and public financing mechanisms, these approaches risk reinforcing existing health inequalities rather than reducing them [42].

5. Conclusions

The findings of this study demonstrate that the modern healthcare system is structurally misaligned with the current global burden of disease. While non-communicable diseases require long-term prevention and integrated management, healthcare systems remain predominantly oriented toward the treatment of already developed conditions.

This misalignment is not driven by technological limitations, but by embedded economic, political, and institutional incentive structures that prioritize short-term, intervention-based outcomes over long-term population health. As a result, increasing healthcare expenditure does not translate into proportional improvements in health outcomes and contributes to rising costs and persistent global inequalities.

Addressing this contradiction requires a systemic reorientation of healthcare models toward prevention, early intervention, and long-term health metrics. This includes restructuring financing mechanisms, strengthening public health capacity, and enabling the evidence-based integration of complementary approaches within healthcare systems. Without such structural changes, continued technological advancement is likely to reinforce existing inefficiencies rather than resolve them.